Cargando…

Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study

As of October 2021, neither established agents (e.g., hydroxychloroquine) nor experimental drugs have lived up to their initial promise as antiviral treatment against SARS-CoV-2 infection. While vaccines are being globally deployed, variants of concern (VOCs) are emerging with the potential for vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schöning, Verena, Kern, Charlotte, Chaccour, Carlos, Hammann, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864116/ https://www.ncbi.nlm.nih.gov/pubmed/35222030 http://dx.doi.org/10.3389/fphar.2022.816429

Ejemplares similares

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
por: Kern, Charlotte, et al.
Publicado: (2021)

Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
por: Chaccour, Carlos, et al.
Publicado: (2017)

Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
por: Fred, Senem Merve, et al.
Publicado: (2022)

An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
por: Tallei, Trina Ekawati, et al.
Publicado: (2021)

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
por: Indari, Omkar, et al.
Publicado: (2021)

Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain
por: Ribes, Marta, et al.
Publicado: (2021)

Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
por: Chang, Sheryl L., et al.
Publicado: (2022)

Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
por: Kern, Charlotte, et al.
Publicado: (2023)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
por: Zakharova, Maria Yu., et al.
Publicado: (2021)

Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells
por: Papies, Jan, et al.
Publicado: (2021)

A Review of Medicinal Plants with Antiviral Activity Available in Bangladesh and Mechanistic Insight Into Their Bioactive Metabolites on SARS-CoV-2, HIV and HBV
por: Bachar, Sitesh C., et al.
Publicado: (2021)

New emerging SARS-CoV-2 variants and antiviral agents
por: Vitiello, A., et al.
Publicado: (2023)

A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant
por: Liu, Changya, et al.
Publicado: (2023)

Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients
por: Schöning, Verena, et al.
Publicado: (2022)

African and Asian Medicinal Plants as a Repository for Prospective Antiviral Metabolites Against HIV-1 and SARS CoV-2: A Mini Review
por: Anywar, Godwin, et al.
Publicado: (2021)

Corrigendum: Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs(®) 7630 in SARS-CoV-2-Infected Human Lung Cells
por: Papies, Jan, et al.
Publicado: (2021)

Virofree, an Herbal Medicine-Based Formula, Interrupts the Viral Infection of Delta and Omicron Variants of SARS-CoV-2
por: Doan, Ly Hien, et al.
Publicado: (2022)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

An update on SARS-CoV-2 immunization and future directions
por: Rana, Rashmi, et al.
Publicado: (2023)

Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
por: Jiang, Wen, et al.
Publicado: (2022)

A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants
por: Dong, Yidan, et al.
Publicado: (2022)

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
por: Islam, Md. Aminul, et al.
Publicado: (2023)

Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients
por: Spuch, Carlos, et al.
Publicado: (2022)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2
por: Bahramsoltani, Roodabeh, et al.
Publicado: (2020)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

Proactive Measures to Combat a SARS-CoV-2 Transmission Among High Risk Patients and Health Care Workers in an Outpatient Dialysis Facility
por: Pillai, Jayandiran, et al.
Publicado: (2021)

Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
por: Marzolini, Catia, et al.
Publicado: (2020)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022)

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
por: Meyerowitz, Eric A., et al.
Publicado: (2022)

Omicron: A highly transmissible SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models
por: Kim, Young-Il, et al.
Publicado: (2022)

Airborne transmission of the Delta variant of SARS-CoV-2 in an auditorium
por: Huang, Jianxiang, et al.
Publicado: (2022)

Household transmission of the SARS-CoV-2 Omicron variant in Denmark
por: Lyngse, Frederik Plesner, et al.
Publicado: (2022)

Competition of SARS-CoV-2 variants on the pandemic transmission dynamics
por: Chen, Jiaqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g8rjomrvk9uool0uil6glu9tc7